ReP USP - Resultado da busca

Artigo de periodico
PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia (2017)
Ito, Matthew K.; Santos, Raul D.
Source: The Journal of Clinical Pharmacology. Unidade: FM
Subjects: LIPÍDEOS, ANTICORPOS MONOCLONAIS, HIPERCOLESTEROLEMIA, DOENÇAS GENÉTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ITO, Matthew K. e SANTOS, Raul D. PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia. The Journal of Clinical Pharmacology, v. 57, n. 1, p. 7-32, 2017Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/jcph.766/epdf. Acesso em: 16 out. 2024.
APA
Ito, M. K., & Santos, R. D. (2017). PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia. The Journal of Clinical Pharmacology, 57( 1), 7-32. doi:10.1002/jcph.766
NLM
Ito MK, Santos RD. PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 1): 7-32.[citado 2024 out. 16 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/jcph.766/epdf
Vancouver
Ito MK, Santos RD. PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 1): 7-32.[citado 2024 out. 16 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/jcph.766/epdf
Artigo de periodico
Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns? (2016)
Banerjee, Yajnavalka; Santos, Raul D.; Al-Rasadi, Khalid; Rizzo, Manfredi
Source: Atherosclerosis. Unidade: FM
Subjects: MUTAÇÃO GENÉTICA, LIPÍDEOS, ANTICORPOS MONOCLONAIS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BANERJEE, Yajnavalka et al. Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns?. Atherosclerosis, v. 248, n. 1, p. 62-75, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2016.02.018. Acesso em: 16 out. 2024.
APA
Banerjee, Y., Santos, R. D., Al-Rasadi, K., & Rizzo, M. (2016). Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns? Atherosclerosis, 248( 1), 62-75. doi:10.1016/j.atherosclerosis.2016.02.018
NLM
Banerjee Y, Santos RD, Al-Rasadi K, Rizzo M. Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns? [Internet]. Atherosclerosis. 2016 ; 248( 1): 62-75.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2016.02.018
Vancouver
Banerjee Y, Santos RD, Al-Rasadi K, Rizzo M. Targeting PCSK9 for therapeutic gains: Have we addressed all the concerns? [Internet]. Atherosclerosis. 2016 ; 248( 1): 62-75.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2016.02.018
Artigo de periodico
Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects (2015)
Jannes, Cinthia E.; Santos, Raul D.; Silva, Pãmela R. de Souza; Turolla, Luciana; Gagliardi, Ana C. M.; Marsiglia, Julia D. C.; Chacra, Ana P.; Miname, Marcio H.; Rocha, Viviane Z.; Salgado Filho, Wilson; Krieger, Jose E.; Pereira, Alexandre C.
Source: Atherosclerosis. Unidade: FM
Subjects: MUTAÇÃO GENÉTICA, APOLIPOPROTEÍNAS, LIPÍDEOS, HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JANNES, Cinthia E. et al. Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects. Atherosclerosis, v. 238, n. 1, p. 101-107, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2014.11.009. Acesso em: 16 out. 2024.
APA
Jannes, C. E., Santos, R. D., Silva, P. R. de S., Turolla, L., Gagliardi, A. C. M., Marsiglia, J. D. C., et al. (2015). Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects. Atherosclerosis, 238( 1), 101-107. doi:10.1016/j.atherosclerosis.2014.11.009
NLM
Jannes CE, Santos RD, Silva PR de S, Turolla L, Gagliardi ACM, Marsiglia JDC, Chacra AP, Miname MH, Rocha VZ, Salgado Filho W, Krieger JE, Pereira AC. Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects [Internet]. Atherosclerosis. 2015 ; 238( 1): 101-107.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2014.11.009
Vancouver
Jannes CE, Santos RD, Silva PR de S, Turolla L, Gagliardi ACM, Marsiglia JDC, Chacra AP, Miname MH, Rocha VZ, Salgado Filho W, Krieger JE, Pereira AC. Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects [Internet]. Atherosclerosis. 2015 ; 238( 1): 101-107.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2014.11.009
Artigo de periodico
Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17) (2015)
Miller, P. Elliott; Martin, Seth S.; Toth, Peter P.; Santos, Raul D.; Blaha, Michael J.; Nasir, Khurram; Virani, Salim S.; Post, Wendy S.; Blumenthal, Roger S.; Jones, Steven R.
Source: Journal of clinical lipidology. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA, LIPOPROTEÍNAS, LIPÍDEOS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MILLER, P. Elliott et al. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17). Journal of clinical lipidology, v. 9, n. 5, p. 676-683, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.jacl.2015.06.015. Acesso em: 16 out. 2024.
APA
Miller, P. E., Martin, S. S., Toth, P. P., Santos, R. D., Blaha, M. J., Nasir, K., et al. (2015). Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17). Journal of clinical lipidology, 9( 5), 676-683. doi:10.1016/j.jacl.2015.06.015
NLM
Miller PE, Martin SS, Toth PP, Santos RD, Blaha MJ, Nasir K, Virani SS, Post WS, Blumenthal RS, Jones SR. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17) [Internet]. Journal of clinical lipidology. 2015 ; 9( 5): 676-683.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.jacl.2015.06.015
Vancouver
Miller PE, Martin SS, Toth PP, Santos RD, Blaha MJ, Nasir K, Virani SS, Post WS, Blumenthal RS, Jones SR. Screening and advanced lipid phenotyping in familial hypercholesterolemia: The Very Large Database of Lipids Study-17 (VLDL-17) [Internet]. Journal of clinical lipidology. 2015 ; 9( 5): 676-683.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/j.jacl.2015.06.015
Artigo de periodico-carta/editorial
Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta] (2013)
Santos, Raul D.
Source: Lancet. Unidade: FM
Subjects: FATORES DE RISCO, LIPÍDEOS, DOENÇAS CARDIOVASCULARES (GENÉTICA), HIPERCOLESTEROLEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Raul D. Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0140-6736(13)60797-7. Acesso em: 16 out. 2024. , 2013
APA
Santos, R. D. (2013). Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta]. Lancet. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0140-6736(13)60797-7
NLM
Santos RD. Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta] [Internet]. Lancet. 2013 ; 381( 9873): 1182.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/S0140-6736(13)60797-7
Vancouver
Santos RD. Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta] [Internet]. Lancet. 2013 ; 381( 9873): 1182.[citado 2024 out. 16 ] Available from: https://doi.org/10.1016/S0140-6736(13)60797-7

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em